Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SKRR to Commence Uranium Drill Program to Test Conductors at Clearwater West (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Ocera Therapeutics OCRX

Healthcare Biotechnology
"Ocera Therapeutics Inc is a clinical-stage biopharmaceutical company. The Company is engaged in the development and commercialization of proprietary compounds to treat acute and chronic orphan liver disease."
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:OCRX)

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Files Class Action Suit Against Ocera Therapeutics, Inc.

GlobeNewswire December 7, 2017

Lifshitz & Miller LLP Announces Investigation of Manitex International, Inc., Novan, Inc., Ocera Therapeutics, Inc., Planet Payment, Inc., RE/MAX Holdings, Inc., Super Micro Computer, Inc. and World Acceptance Corporation

PR Newswire November 16, 2017

SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Ocera Therapeutics, Inc. - OCRX

PR Newswire November 2, 2017

OCERA THERAPEUTICS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout

Business Wire November 2, 2017

Mid-Afternoon Market Update: Ocera Therapeutics Surges Following Acquisition News; IMPINJ Shares Plunge

Benzinga.com  November 2, 2017

Mid-Day Market Update: AAC Holdings Climbs On Earnings Beat; KEMET Shares Slide

Benzinga.com  November 2, 2017

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of Clifton Bancorp Inc. to Kearny Financial Corp. is Fair to Shareholders – CSBK

Business Wire November 2, 2017

Mallinckrodt To Acquire Ocera Therapeutics And OCR-002, Its Proprietary Therapy In Development For Treatment Of Hepatic Encephalopathy

PR Newswire November 2, 2017

Ocera Presents Three Posters and an Oral Presentation on OCR-002 at the AASLD Liver Meeting®

GlobeNewswire October 20, 2017
View More News ››

Opinion & Analysis (NDAQ:OCRX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:OCRX)

Todays audio webcast

you can listen it here: http://wsw.com/webcast/needham80/ocrx/index.aspx possible partnership annoucement. 
DaFoolOnTheHill - April 4, 2017
View more Bullboard ››

Safe Supply Streaming Co Ltd.

Safe Supply Streaming Co Ltd.

Safe Supply Streaming Co Ltd. is engaged in investing in the legal and regulated supply of drugs. The Company’s focus is ...
View More »